Hypercalcemia is rarely seen in childhood malignancies and the incidence has been reported to range from 0.4 to 1.3%. 1 The most common malignancies associated with hypercalcemia include AML and ...

New research attempts to answer some of the mystery related to the causes and impact of hypercalcemia in patients with newly diagnosed multiple myeloma. Hypercalcemia is caused by many factors in ...

Excessive calcium in the blood, known as hypercalcemia, can disrupt the heart’s electrical system, potentially leading to an irregular heartbeat or arrhythmia. Hypercalcemia is more likely to cause a ...

Goldner 5 makes several important points in this review. First, the clinician must determine if the hypercalcemia is indeed a result of malignancy, rather than just associated with a nonmalignant ...

Malignancy-related hypercalcemia (MRH) is associated with a dismal prognosis. The widespread use of bisphosphonates (BPs), availability of more effective drugs in cancer treatment, and improvement in ...

A 48-year-old woman was given a diagnosis of infiltrating ductal breast carcinoma (T2N1M0; grade I; positive for estrogen receptors, progesterone receptors and human epidermal receptor-2 [HER2] status ...

This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they ...

Hypercalcemia of malignancy (HCM) is the most common metabolic complication seen in patients with cancer, and is associated with a high degree of morbidity and mortality. It affects an estimated 2%–30 ...

Familial hypocalciuric hypercalcemia: It is a condition which is hereditary and runs in families and is characterized by 3 things – hypercalcemia (S.Ca >10.2 mg/dl), hypocalciuria (Ca excretion rate 0 ...

Vitamin A toxicity should be considered in the differential diagnosis for severe hypercalcemia. Symptoms of vitamin A toxicity are nonspecific, and may include nausea, fatigue, lethargy, anorexia, ...